Update on the biology and treatment of lymphedema

Current Treatment Options in Cardiovascular Medicine

Volumn 14, Issue 2, 2012, Pages 184-192

  Rockson, Stanley G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immune traffic; Lymphangiogenesis; Lymphedema

Indexed keywords

VASCULOTROPIN C;

ARTICLE; COMPLEX DECONGESTIVE PHYSIOTHERAPY; COMPRESSION GARMENT; COMPRESSION THERAPY; CYTOREDUCTIVE SURGERY; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTERVENTION STUDY; LIFESTYLE MODIFICATION; LIPOSUCTION; LYMPH FLOW; LYMPHANGIOGENESIS; LYMPHEDEMA; MICROSURGERY; NONHUMAN; PERIPHERAL EDEMA; PHLEBOGRAPHY; PHYSIOTHERAPY; POINT OF CARE TESTING; TREATMENT RESPONSE;

EID: 84861095572     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-012-0170-0     Document Type: Article

References (53)

1. Rockson SG. Lymphedema. Am J Med. 2001;110(4):288-95. (Pubitemid 32187290)
2. Rockson SG. How can lymphatic research influence lymphatic education? Lymphat Res Biol. 2004;2(2):67-8. (Pubitemid 39440139)
3. Rockson SG, Granger DN, Skeff KM, Chaite W. Lymphatic biology and disease: is it being taught? Who is listening? Lymphat Res Biol. 2004;2(2):86-95. (Pubitemid 39440142)
4. Rockson SG. Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol. 2008;52(10):799-806. This is a review of current diagnostic and therapeutic approaches to lymphedema and other pathologic conditions of the lymphatic circulation.
5. Norrmen C, Tammela T, Petrova TV, Alitalo K. Biological basis of therapeutic lymphangiogenesis. Circulation. 2011;123(12):1335-51. This is an excellent review of the current insights into molecular mechanisms of normal and abnormal lymphatic vascular development and repair.
6. Rockson SG. The unique biology of lymphatic edema. Lymphat Res Biol. 2009;7(2):97-100.
7. Oliver G. Lymphatic vasculature development. Nat Rev Immunol. 2004;4(1):35-45. (Pubitemid 38084130)
8. Hodge LM, Downey HF. Lymphatic pump treatment enhances the lymphatic and immune systems. Exp Biol Med (Maywood). 2011;236(10):1109-15.
9. Detry B, Bruyere F, Erpicum C, Paupert J, Lamaye F, Maillard C, Lenoir B, Foidart JM, Thiry M, Noel A. Digging deeper into lymphatic vessel formation in vitro and in vivo. BMC Cell Biol. 2011;12:29. This article shows that lymphatic vessel formation in disease is comprised of integral vascular responses that can be demonstrated in vitro and in vivo.
10. Nakamura K, Rockson SG. Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease. Lymphat Res Biol. 2008;6(3-4):181-9.
11. An A, Rockson SG. The potential for molecular treatment strategies in lymphatic disease. Lymphat Res Biol. 2004;2(4):173-81. (Pubitemid 40227680)
12. Ferrell RE, Kimak MA, Lawrence EC, Finegold DN. Candidate gene analysis in primary lymphedema. Lymphat Res Biol. 2008;6(2):69-76. (Pubitemid 351873442)
13. Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol. 2008;6(2):65-8. (Pubitemid 351873446)
14. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177(3):184-7. discussion 188.
15. Ridner SH. The psycho-social impact of lymphedema. Lymphat Res Biol. 2009;7(2):109-12.
16. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44(1):43-57. (Pubitemid 36077712)
17. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002; (in press).
18. Tabibiazar R Cheung L, Han J, Swanson J, Beilhack A, An A, Dadras SS, Rockson N, Joshi S, Wagner R Rockson SG. Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 2006;3(7):e254.
19. Avraham T, Daluvoy S, Zampell J, Yan A, Haviv YS, Rockson SG, Mehrara BJ. Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol. 2010;177(6):3202-14.
20. Zampell JC, Yan A, Avraham T, Andrade V, Malliaris S, Aschen S, Rockson SG, Mehrara BJ. Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema. Am J Physiol Cell Physiol. May; 300(5):C1107-1121. This is an animal study that underscores the importance of tissue injury responses as an integral component of the biology of lymphedema.
21. Beilhack A, Rockson SG. Immune traffic: a functional overview. Lymphat Res Biol. 2003;1(3):219-34.
22. Johnson LA, Jackson DG. Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci. 2008;1131:119-33. (Pubitemid 351758509)
23. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;21(7):1505-13. (Pubitemid 34614607)
24. Wigle JT, Oliver G Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98(6):769-78. (Pubitemid 29446894)
25. Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, Oliver G Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet. 2005;37(10):1072-81. (Pubitemid 41486659)
26. Brorson H, Ohlin K, Olsson G, Karlsson M. Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol. 2009;7(1).
27. Brorson H, Ohlin K, Olsson G, Langstrom G, Wiklund I, Svensson H. Quality of life following liposuction and conservative treatment of arm lymphedema. Lymphology. 2006;39(1):8-25.
28. Brorson H. Liposuction in arm lymphedema treatment. Scand J Surg. 2003;92(4):287-95. (Pubitemid 38095095)
29. Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg. 1998;102(4):1058-67. discussion 1068. (Pubitemid 128723394)
30. Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A, An A, Rockson SG. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs. 2006;20(6):363-70. (Pubitemid 46089663)
31. Schneider M, Ny A, Ruiz de Almodovar C, Carmeliet P. A new mouse model to study acquired lymphedema. PLoS Med. 2006;3(7):e264.
32. Jin D, An A, Liu J, Nakamura K, Rockson S. Therapeutic Responses to Exogenous VEGF-C Administration in Experimental Lymphedema: Immunohistochemical and Molecular Characterization Lymphat Res Biol. 2009;7(1).
33. Lahteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, Lahteenvuo J, Kholova I, Alitalo K, Yla-Herttuala S, Saaristo A. Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation. 2011;123(6):613-20.
34. Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer. 2006;95(12):1611-25. (Pubitemid 44950785)
35. Cornish B. Bioimpedance analysis: scientific background. Lymphat Res Biol Spring. 2006;4(1):47-50.
36. Ward LC. Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring. Breast Cancer Res Treat. 2006;4(1):51-6.
37. Szuba A, Cooke JP, Yousuf S, Rockson SG. Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med. 2000;109(4):296-300.
38. Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009;361(7):664-73.
39. Szuba A, Razavi M, Rockson SG. Diagnosis and treatment of concomitant venous obstruction in patients with secondary lymphedema. J Vasc Interv Radiol. 2002;13(8):799-803.
40. Raju S, Furrh JBT, Neglen P. Diagnosis and treatment of venous lymphedema. 2011; J Vasc Surg. Sep. 27 [Epub ahead of print].
41. Damstra RJ, Voesten HG, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat. 2009;113(2):199-206.
42. Weiss M, Baumeister RG, Hahn K. Dynamic lymph flowimaginginpatientswith oedemaofthelower limb for evaluation of the functional outcome after autologous lymph vessel transplantation: an 8-year follow-up study. Eur JNucl Med Mol Imaging. 2003;30(2):202-6. (Pubitemid 36686838)
43. Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28(6):609-13. (Pubitemid 38802800)
44. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg. 2006;243(3):313-5. (Pubitemid 43327760)
45. Brorson H, Svensson H. Complete reduction of lymphoedema of the arm by liposuction after breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1997;31(2):137-43.
46. McGeown JG, McHale NG, Thornbury KD. Effects of varying patterns of external compression on lymph flow in the hindlimb of the anaesthetized sheep. J Physiol. 1988;397:449-57. (Pubitemid 18062583)
47. Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer. 2002;95(11):2260-7. (Pubitemid 35351130)
48. Wilburn O, Wilburn P, Rockson SG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. BMC Cancer. 2006;6:84.
49. Rockson SG. Current concepts and future directions in the diagnosis and management of lymphatic vascular disease. Vasc Med. 2010;15(3):223-31.
50. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 2001;98(22):12677-82. (Pubitemid 33020005)
51. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000;25(2):153-9. (Pubitemid 30394984)
52. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome [in process citation]. Am J Hum Genet. 2000;67(6):1382-8.
53. Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Steijlen PM, Fryns JP, Van Steensel MA, Vikkula M. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema- telangiectasia. Am J Hum Genet. 2003;72(6):1470-8. (Pubitemid 36628386)